Microbot Medical (MBOT) regains NASDAQ compliance

Microbot Medical (NASDAQ: MBOT) a Delaware-based company specializing in surgical and medical instruments, announced today that it has regained compliance with Nasdaq's minimum bid price requirement. The company received a notification from Nasdaq Stock Market LLC confirming that the minimum closing bid price for Microbot Medical's common stock remained at or above $1.00 per share for 15 consecutive business days, from December 26, 2024, to January 17, 2025.

You May Also Be Interested In

• Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
• Huang Calls AI 'the Great Equalizer' During G20 Event
• ReconAfrica Announces Upsize of Bought-Deal Public Offering to C$19 Million to Conduct Horizontal Sidetrack and Production Testing Program at the Kavango West 1X of the Huttenberg Formation